Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus–Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Plastic and Reconstructive Surgery

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PRS.0000000000000878PMID 25626794PMCID PMC4946621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymph Node Transfer and Perinodal Lymphatic Growth Factor Treatment for Lymphedema

  2013cited by this paper
• Lentiviral Transduction of Face and Limb Flaps: Implications for Immunomodulation of Vascularized Composite Allografts

  2012cited by this paper
• Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction.

  2012cited by this paper
• High sacrectomy for locally recurrent rectal cancer: Can long‐term survival be achieved?

  2011cited by this paper
• Pharmacological interventions for improving adenovirus usage in gene therapy.

  2011cited by this paper
• RNA interference in the clinic: challenges and future directions

  2011cited by this paper
• Perforator flaps in breast reconstruction.

  2010cited by this paper
• Microsurgical free flap in head and neck reconstruction

  2010cited by this paper
• Recent advances in lentiviral vector development and applications.

  2010cited by this paper
• Sternal/para-sternal resection for parasternal local recurrence in breast cancer.

  2010cited by this paper
• Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery

  2009cited by this paper
• Post-mastectomy breast reconstruction: a history in evolution.

  2009cited by this paper
• State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.

  2009cited by this paper
• Treating Chronic Wound Infections with Genetically Modified Free Flaps

  2009cited by this paper
• Using Genetically Modified Microvascular Free Flaps to Deliver Local Cancer Immunotherapy with Minimal Systemic Toxicity

  2008cited by this paper
• Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.

  2008cited by this paper
• Plastic Surgical Delivery Systems for Targeted Gene Therapy

  2008cited by this paper
• Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation

  2007cited by this paper
• Therapy of cancer by cytokines mediated by gene therapy approach

  2006cited by this paper
• Enzyme-Catalyzed Activation of Anticancer Prodrugs

  2004cited by this paper
• Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.

  2003cited by this paper
• Interleukin-12 in anti-tumor immunity and immunotherapy.

  2002cited by this paper
• Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

  2001cited by this paper
• A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme

  2000cited by this paper
• Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.

  1996cited by this paper
• IL-12: a key cytokine in immune regulation.

  1996cited by this paper
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

  1994cited by this paper
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors

  1993cited by this paper
• The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings

  1980cited by this paper
• Findings from NSABP protocol no. B‐04‐comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome

  1980cited by this paper
• I. A Clinical and Histological Study of certain Adenocarcinomata of the Breast: and a Brief Consideration of the Supraclavicular Operation and of the Results of Operations for Cancer of the Breast from 1889 to 1898 at the Johns Hopkins Hospital.

  1898cited by this paper

• Biologic Brachytherapy: Genetically Modified Surgical Flap as a Therapeutic Tool—A Systematic Review of Animal Studies

  2024cites this paper
• CXCL12-targeted immunomodulatory gene therapy reduces radiation-induced fibrosis in healthy tissues.

  2024cites this paper
• Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes

  2023cites this paper
• Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence

  2023cites this paper
• Lentivirus-mediated CDglyTK gene-modified free flaps by intra-artery perfusion show targeted therapeutic efficacy in rat model of breast cancer

  2019cites this paper
• Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues

  2018cites this paper
• CRISPR Craft: DNA Editing the Reconstructive Ladder

  2018cites this paper